Cyclopentoiate
Cyclopentoiate Brand names, Cyclopentoiate Analogs
Cyclopentoiate Brand Names Mixture
- No information avaliable
Cyclopentoiate Chemical_Formula
C17H25NO3
Cyclopentoiate RX_link
No information avaliable
Cyclopentoiate fda sheet
Cyclopentoiate msds (material safety sheet)
Cyclopentoiate Synthesis Reference
No information avaliable
Cyclopentoiate Molecular Weight
291.385 g/mol
Cyclopentoiate Melting Point
139 oC (hydrochloride salt)
Cyclopentoiate H2O Solubility
No information avaliable
Cyclopentoiate State
Solid
Cyclopentoiate LogP
3.124
Cyclopentoiate Dosage Forms
Ophthalmic solution (eye drops)
Cyclopentoiate Indication
Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.
Cyclopentoiate Pharmacology
Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.
Cyclopentoiate Absorption
Absorbed following ophthalmic administration.
Cyclopentoiate side effects and Toxicity
Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.
Cyclopentoiate Patient Information
No information avaliable
Cyclopentoiate Organisms Affected
Humans and other mammals
